Progerinin clinical trials
How each study uses progerinin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the progerinin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2020 (1)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Who runs them
Industry 3 · Other 0
PRG Science & Technology Co., Ltd. (3)
Studies
Open first, then newest update. How each study uses progerinin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner SyndromeRecruitingPhase 2PRG Science & Technology Co., Ltd.NCT05847179Written as Progerinin
- Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS)CompletedPhase 2PRG Science & Technology Co., Ltd.NCT06775041Written as Progerinin
- Phase I Study of Progerinin in Healthy VolunteersCompletedPhase 1PRG Science & Technology Co., Ltd.NCT04512963Written as Progerinin
Codes
What other systems call progerinin · ClinicalTrials.gg INT014772
- UNII (FDA) 426P9HSR8IPROGERININOne source FDA
- NCI Thesaurus C206974ProgerininOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 426P9HSR8I | PROGERININ | One source FDA |
| NCI Thesaurus | C206974 | Progerinin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.